|
1
|
Smeitink J, van den Heuvel L and DiMauro
S: The genetics and pathology of oxidative phosphorylation. Nat Rev
Genet. 2:342–352. 2001.PubMed/NCBI View
Article : Google Scholar
|
|
2
|
Andreyev AY, Kushnareva YE and Starkov AA:
Mitochondrial metabolism of reactive oxygen species. Biochemistry
(Mosc). 70:200–214. 2005.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Taanman JW: The mitochondrial genome:
Structure, transcription, translation and replication. Biochim
Biophys Acta. 1410:103–123. 1999.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Bohr VA: Repair of oxidative DNA damage in
nuclear and mitochondrial DNA, and some changes with aging in
mammalian cells. Free Radic Biol Med. 32:804–812. 2002.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Santos JH, Hunakova L, Chen Y, Bortner C
and Van Houten B: Cell sorting experiments link persistent
mitochondrial DNA damage with loss of mitochondrial membrane
potential and apoptotic cell death. J Biol Chem. 278:1728–1734.
2003.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Taylor RW and Turnbull DM: Mitochondrial
DNA mutations in human disease. Nat Rev Genet. 6:389–402.
2005.PubMed/NCBI View
Article : Google Scholar
|
|
7
|
Zapico SC and Ubelaker DH: mtDNA Mutations
and their role in aging, diseases and forensic sciences. Aging Dis.
4:364–380. 2013.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Li H, Slone J, Fei L and Huang T:
Mitochondrial DNA variants and common diseases: A mathematical
model for the diversity of age-related mtDNA mutations. Cells.
8(8)2019.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Alharbi MA, Al-Kafaji G, Khalaf NB,
Messaoudi SA, Taha S, Daif A and Bakhiet M: Four novel mutations in
the mitochondrial ND4 gene of complex I in patients with multiple
sclerosis. Biomed Rep. 11:257–268. 2019.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Escames G, López LC, García JA,
García-Corzo L, Ortiz F and Acuña-Castroviejo D: Mitochondrial DNA
and inflammatory diseases. Hum Genet. 131:161–173. 2012.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Da Pozzo P, Cardaioli E, Radi E and
Federico A: Sequence analysis of the complete mitochondrial genome
in patients with mitochondrial encephaloneuromyopathies lacking the
common pathogenic DNA mutations. Biochem Biophys Res Commun.
324:360–364. 2004.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Fauser S, Luberichs J, Besch D and
Leo-Kottler B: Sequence analysis of the complete mitochondrial
genome in patients with Leber's hereditary optic neuropathy lacking
the three most common pathogenic DNA mutations. Biochem Biophys Res
Commun. 295:342–347. 2002.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Peters BP, Weissman FG and Gill MA:
Pathophysiology and treatment of psoriasis. Am J Health Syst Pharm.
57:645–659; quiz 660-661. 2000.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Nestle FO, Kaplan DH and Barker J:
Psoriasis. N Engl J Med. 361:496–509. 2009.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Langley RG, Krueger GG and Griffiths CE:
Psoriasis: Epidemiology, clinical features, and quality of life.
Ann Rheum Dis. 64 (Suppl 2):ii18–ii23; discussion ii24-ii25.
2005.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Shelleh HH and Al-Hatiti HS: Pattern of
skin diseases in a hospital in southwestern Saudi Arabia. Saudi Med
J. 25:507–510. 2004.PubMed/NCBI
|
|
17
|
Alakloby OM: Pattern of skin diseases in
Eastern Saudi Arabia. Saudi Med J. 26:1607–1610. 2005.PubMed/NCBI
|
|
18
|
al-Fouzan AS and Nanda A: A survey of
childhood psoriasis in Kuwait. Pediatr Dermatol. 11:116–119.
1994.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Gisondi P, Tessari G, Conti A, Piaserico
S, Schianchi S, Peserico A, Giannetti A and Girolomoni G:
Prevalence of metabolic syndrome in patients with psoriasis: A
hospital-based case-control study. Br J Dermatol. 157:68–73.
2007.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Lønnberg AS, Skov L, Skytthe A, Kyvik KO,
Pedersen OB and Thomsen SF: Association of psoriasis with the risk
for type 2 diabetes mellitus and obesity. JAMA Dermatol.
152:761–767. 2016.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Gelfand JM: Psoriasis, Type 2 Diabetes
Mellitus, and Obesity: Weighing the Evidence. JAMA Dermatol.
152:753–754. 2016.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Cohen AD, Sherf M, Vidavsky L, Vardy DA,
Shapiro J and Meyerovitch J: Association between psoriasis and the
metabolic syndrome. A cross-sectional study. Dermatology.
216:152–155. 2008.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Cade WT: Diabetes-related microvascular
and macrovascular diseases in the physical therapy setting. Phys
Ther. 88:1322–1335. 2008.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Einarson TR, Acs A, Ludwig C and Panton
UH: Prevalence of cardiovascular disease in type 2 diabetes: A
systematic literature review of scientific evidence from across the
world in 2007-2017. Cardiovasc Diabetol. 17(83)2018.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Neimann AL, Shin DB, Wang X, Margolis DJ,
Troxel AB and Gelfand JM: Prevalence of cardiovascular risk factors
in patients with psoriasis. J Am Acad Dermatol. 55:829–835.
2006.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Gelfand JM, Neimann AL, Shin DB, Wang X,
Margolis DJ and Troxel AB: Risk of myocardial infarction in
patients with psoriasis. JAMA. 296:1735–1741. 2006.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Schwandt A, Bergis D, Dapp A, Ebner S,
Jehle PM, Köppen S, Risse A, Zimny S and Holl RW: Psoriasis and
diabetes: A Multicenter study in 222078 type 2 diabetes patients
reveals high levels of depression. J Diabetes Res.
2015(792968)2015.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Jiang W, Li R, Zhang Y, Wang P, Wu T, Lin
J, Yu J and Gu M: Mitochondrial DNA mutations associated with type
2diabetes mellitus in Chinese Uyghur population. Sci Rep.
7(16989)2017.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Poulton J, Luan J, Macaulay V, Hennings S,
Mitchell J and Wareham NJ: Type 2 diabetes is associated with a
common mitochondrial variant: Evidence from a population-based
case-control study. Hum Mol Genet. 11:1581–1583. 2002.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Charoute H, Kefi R, Bounaceur S, Benrahma
H, Reguig A, Kandil M, Rouba H, Bakhchane A, Abdelhak S and Barakat
A: Novel variants of mitochondrial DNA associated with type 2
diabetes mellitus in Moroccan population. Mitochondrial DNA A DNA
Mapp Seq Anal. 29:9–13. 2018.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Crispim D, Estivalet AAF, Roisenberg I,
Gross JL and Canani LH: Prevalence of 15 mitochondrial DNA
mutations among type 2 diabetic patients with or without clinical
characteristics of maternally inherited diabetes and deafness. Arq
Bras Endocrinol Metabol. 52:1228–1235. 2008.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Coto-Segura P, Santos-Juanes J, Gómez J,
Alvarez V, Díaz M, Alonso B, Corao AI and Coto E: Common European
mitochondrial haplogroups in the risk for psoriasis and psoriatic
arthritis. Genet Test Mol Biomarkers. 16:621–623. 2012.PubMed/NCBI View Article : Google Scholar
|
|
33
|
World Health O and International Diabetes:
Definition and diagnosis of diabetes mellitus and intermediate
hyperglycaemia. Report of a WHO/IDF Consultation. World Health
Organization, Geneva, 2006.
|
|
34
|
Al-Kafaji G, Aljadaan A, Kamal A and
Bakhiet M: Peripheral blood mitochondrial DNA copy number as a
novel potential biomarker for diabetic nephropathy in type 2
diabetes patients. Exp Ther Med. 16:1483–1492. 2018.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Bandelt HJ, Kloss-Brandstätter A, Richards
MB, Yao YG and Logan I: The case for the continuing use of the
revised Cambridge Reference Sequence (rCRS) and the standardization
of notation in human mitochondrial DNA studies. J Hum Genet.
59:66–77. 2014.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Brandon MC, Lott MT, Nguyen KC, Spolim S,
Navathe SB, Baldi P and Wallace DC: MITOMAP: A human mitochondrial
genome database - 2004 update. Nucleic Acids Res. 33:D611–D613.
2005.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Hahn A and Zuryn S: Mitochondrial Genome
(mtDNA) mutations that generate reactive oxygen species.
Antioxidants. 8(8)2019.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Tarantino G, Citro V and Capone D:
Nonalcoholic fatty liver disease: A challenge from mechanisms to
therapy. J Clin Med. 9(15)2019.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Wong LJ, Liang MH, Kwon H, Park J, Bai RK
and Tan DJ: Comprehensive scanning of the entire mitochondrial
genome for mutations. Clin Chem. 48:1901–1912. 2002.PubMed/NCBI
|
|
40
|
Negishi Y, Hattori A, Takeshita E, Sakai
C, Ando N, Ito T, Goto Y and Saitoh S: Homoplasmy of a
mitochondrial 3697G>A mutation causes Leigh syndrome. J Hum
Genet. 59:405–407. 2014.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Carelli V, Giordano C and d'Amati G:
Pathogenic expression of homoplasmic mtDNA mutations needs a
complex nuclear-mitochondrial interaction. Trends Genet.
19:257–262. 2003.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Itsara LS, Kennedy SR, Fox EJ, Yu S,
Hewitt JJ, Sanchez-Contreras M, Cardozo-Pelaez F and Pallanck LJ:
Oxidative stress is not a major contributor to somatic
mitochondrial DNA mutations. PLoS Genet.
10(e1003974)2014.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Hirst J: Towards the molecular mechanism
of respiratory complex I. Biochem J. 425:327–339. 2009.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Sharma LK, Lu J and Bai Y: Mitochondrial
respiratory complex I: Structure, function and implication in human
diseases. Curr Med Chem. 16:1266–1277. 2009.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Wu J, Luo X, Thangthaeng N, Sumien N, Chen
Z, Rutledge MA, Jing S, Forster MJ and Yan LJ: Pancreatic
mitochondrial complex I exhibits aberrant hyperactivity in
diabetes. Biochem Biophys Rep. 11:119–129. 2017.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Buske OJ, Manickaraj A, Mital S, Ray PN
and Brudno M: Identification of deleterious synonymous variants in
human genomes. Bioinformatics. 29:1843–1850. 2013.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Supek F, Miñana B, Valcárcel J, Gabaldón T
and Lehner B: Synonymous mutations frequently act as driver
mutations in human cancers. Cell. 156:1324–1335. 2014.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Gotea V, Gartner JJ, Qutob N, Elnitski L
and Samuels Y: The functional relevance of somatic synonymous
mutations in melanoma and other cancers. Pigment Cell Melanoma Res.
28:673–684. 2015.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Omasanggar R, Yu CY, Ang GY, Emran NA,
Kitan N, Baghawi A, Falparado Ahmad A, Abdullah MA, Teh LK and
Maniam S: Mitochondrial DNA mutations in Malaysian female breast
cancer patients. PLoS One. 15(e0233461)2020.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Zhai K, Chang L, Zhang Q, Liu B and Wu Y:
Mitochondrial C150T polymorphism increases the risk of cervical
cancer and HPV infection. Mitochondrion. 11:559–563.
2011.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Naess K, Freyer C, Bruhn H, Wibom R, Malm
G, Nennesmo I, von Döbeln U and Larsson NG: MtDNA mutations are a
common cause of severe disease phenotypes in children with Leigh
syndrome. Biochim Biophys Acta. 1787:484–490. 2009.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Hsouna S, Ben Halim N, Lasram K, Arfa I,
Jamoussi H, Bahri S, Ammar SB, Miladi N, Abid A, Abdelhak S, et al:
Association study of mitochondrial DNA polymorphisms with type 2
diabetes in Tunisian population. Mitochondrial DNA. 26:367–372.
2015.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Tawata M, Ohtaka M, Iwase E, Ikegishi Y,
Aida K and Onaya T: New mitochondrial DNA homoplasmic mutations
associated with Japanese patients with type 2 diabetes. Diabetes.
47:276–277. 1998.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Zhu Y, Gu X and Xu C: A Mitochondrial DNA
A8701G mutation associated with maternally inherited hypertension
and dilated cardiomyopathy in a Chinese pedigree of a
consanguineous marriage. Chin Med J (Engl). 129:259–266.
2016.PubMed/NCBI View Article : Google Scholar
|
